27
Views
153
CrossRef citations to date
0
Altmetric
Article

Inhibition of ADP/ATP Exchange in Receptor-Interacting Protein-Mediated Necrosis

, , , &
Pages 2215-2225 | Received 31 Aug 2005, Accepted 21 Dec 2005, Published online: 27 Mar 2023
 

Abstract

Receptor-interacting protein (RIP) has been implicated in the induction of death receptor-mediated, nonapoptotic cell death. However, the mechanisms remain to be elucidated. Here we show that tumor necrosis factor alpha induced RIP-dependent inhibition of adenine nucleotide translocase (ANT)-conducted transport of ADP into mitochondria, which resulted in reduced ATP and necrotic cell death. The inhibition of ADP/ATP exchange coincided with the loss of interaction between ANT and cyclophilin D and the inability of ANT to adopt the cytosolic conformational state, which prevented cytochrome c release. Neither overexpression of Bcl-xL nor inhibition of reactive oxygen species prevented necrosis. In contrast, the ectopic expression of ANT or cyclophilin D was effective at preventing cell death. These observations demonstrate a novel mechanism initiated through death receptor ligation and mediated by RIP that results in the suppression of ANT activity and necrosis.

Supplemental material for this article may be found at http://mcb.asm.org/.

This work was supported by National Institutes of Health grants AR049217 and AR048269 to R.M.P.

We thank M. Paniaqua and L. Reynolds from the Robert Lurie Cancer Center for assistance with flow cytometry and electron microscopy and N. Chandel and K. Machida for helpful discussions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.